Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection

Table 5

Results of the main analysis. Hospitalisation episodes overlapping the date of RLAI initiation are allocated to the period before initiation. Sample unit (𝑁) is the patient.

Endpoints	Before initiation		After initiation		Difference
	Mean (SE)	95% CI	Mean (SE)	95% CI	Mean (SE)	95% CI
Inpatient bed-days per patient-year (𝑁=177)	62.89 (4.16)	(54.74; 71.04)	38 (5.19)	(27.83; 48.17)	−24.89 (5.93)	(−36.51; 13.26)
No. hospitalizations per patient-year (𝑁=177)	0.93 (0.05)	(0.83; 1.03)	0.74 (0.09)	(0.57; 0.91)	−0.19 (0.09)	(−0.36; −0.01)
Hospital costs per patient-year, € (𝑁=177)	28,046 (1,782)	(24,554; 31,539)	16,098 (2,117)	(11,949; 20,248)	−11,948 (2,555)	(−16,995; −6,941)
Cost of other antipsychotic agents, € per patient-year (𝑁=177)	907 (148)	(617; 1,197)	1,130 (174)	(788; 1,471)	233 (135)	(−43; 488)
Cost of RLAI per patient-year, € (𝑁=177)	—	—	4,193 (196)	(3,809; 4,576)	—	—